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Antimicrobial resistance in Escherichia coli isolated from pet dogs can be considered a poten-
tial threat of infection for the human population. Our objective was to characterize the
resistance pattern, extended spectrum beta-lactamase production and genetic relatedness
of  multiresistant E. coli strains isolated from dogs (n = 134), their owners (n = 134), and humans
who claim to have no contact with dogs (n = 44, control), searching for sharing of strains. The
strains were assessed for their genetic relatedness by phylogenetic grouping and pulsed-ﬁeld
gel  electrophoresis. Multiresistant E. coli strains were isolated from 42 (31.3%) fecal samples
from pairs of dogs and owners, totaling 84 isolates, and from 19 (43.1%) control group sub-
jects. The strains showed high levels of resistance to ampicillin, streptomycin, tetracycline,
trimethoprim and sulfamethoxazole regardless of host species or group of origin. The blaTEM,
blaCTX-M, and blaSHV genes were detected in similar proportions in all groups. All isolates pos-
itive for bla genes were ESBL producers. The phylogenetic group A was the most prevalent,
irrespective of the host species. None of the strains belonging to the B2 group contained bla
genes. Similar resistance patterns were found for strains from dogs, owners and controls;
furthermore, identical PFGE proﬁles were detected in four (9.5%) isolate pairs from dogs and
owners, denoting the sharing of strains. Pet dogs were shown to be a potential household
source of multiresistant E. coli strains.
©  2016 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda. This is
an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).∗ Corresponding author.
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he implications of microbial resistance for public health have
ncreased the interest of the scientiﬁc community in the pres-
nce and circulation of resistant organisms between pets and
he human population. Among pets, dogs share a close prox-
mity with humans, and proximity is known to increase the
ossibility of transmitting resistant bacteria between these
ost species. It is important to note that the bacterial ability to
ransfer genetic cassettes, which confer resistance to several
lasses of drugs, and observations of the spread of resistance
ave increased in recent years.1,2 The molecular character-
zation of antimicrobial resistance could be very useful not
nly in surveillance studies and monitoring and tracking of
ultidrug-resistant strains but also in obtaining information
bout commonality among human and animal bacterial iso-
ates.
Escherichia coli is characterized by a substantial genetic
iversity, broad host range, versatility in pathogenic potential,
nd distribution between hosts in the environment.3 E. coli
solates, commensal or pathogenic, obtained from humans
nd other animals, have been extensively studied and char-
cterized in terms of their drug resistance proﬁles based on
heir phenotypic sensitivity to various antimicrobial drugs
s well as by their genetic resistance to major classes of
ntibiotics detected by molecular assays of genetic simi-
arities among isolates.4–6 Similarities in resistance proﬁles
mong isolates have been described, and the molecular char-
cterization of these isolates has demonstrated substantial
ifferences depending on the population and the geographic
egion of origin. In general, comparisons of resistance proﬁles
re performed on samples of individuals who are not nec-
ssarily cohabiting and are therefore not epidemiologically
elated. Further studies are needed to characterize related
uman and dog isolates in Brazil as well as to investigate
he possibility of humans and canines sharing multiresistant
trains. The aim of this study was to compare resistance pro-
les of isolates of E. coli from the intestinal tracts of dogs and
heir owners and to assess the presence of extended-spectrum
eta-lactamase (ESBL) genes in E. coli isolates recovered from
ogs and humans living in the same household. In addition,
e intended to characterize the genetic relatedness among
ntimicrobial-resistant isolates.
aterials  and  methods
tudy  design
 total of 134 fecal sample pairs from dogs and their owners of
ouseholds located in the city of Rio das Ostras (Rio de Janeiro,
razil) were studied. Every owner (>18 years old) chosen for
he study had only one dog. A control group of 44 fecal sam-
les from individuals who  claimed have no contact with dogs
as also included in the study. The samples were collected
or one year (2010), and the human and dog participants had
ot been using antimicrobials for at least three months prior
o the study. Bacterial strains were selected using a proto-
ol for growth in selective media containing antibiotics. The
rotocol of this study was submitted to the Research Ethicso l o g y 4 7 (2 0 1 6) 150–158 151
Committee of HUAP/UFF (CAAE0146.0.258.000-09) and the Ani-
mal  Ethics Committee of the NAL/UFF (NAL00126-09), and it
was approved and certiﬁed by both committees.
Bacterial  samples
Fecal samples on swabs from dogs and humans were obtained
and processed for testing. Typical E. coli colonies were selected
and tested for antimicrobial susceptibility. After enrichment
growth in E. coli broth containing gentamicin (8 g/mL) and
cephalothin (32 g/mL), the samples were cultured on Mac-
Conkey agar (Himedia, Mumbai, India) supplemented with
gentamicin (8 g/mL) and cephalothin (32 g/mL) to promote
the growth of potentially multidrug-resistant E. coli strains.7
Samples that did not grow were discarded. For quality con-
trol purposes, each sample was also inoculated into medium
without antibiotics. Three colonies, believed to be E. coli, were
chosen from the MacConkey agar containing antibiotics and
identiﬁed based on standard biochemical tests.8
The characterization portion of this study included only
isolates that displayed multidrug resistance, which was
deﬁned as resistance to two or more  classes of drugs. With
our protocol of selective isolation and susceptibility testing,
one hundred and three multidrug-resistant E. coli isolates were
identiﬁed from dogs (n = 42), their respective owners (n = 42)
and control subjects (n = 19).
Antimicrobial  susceptibility  testing
E. coli isolates were tested for antimicrobial susceptibility to
the drugs ampicillin (AMP), amoxicillin + clavulanate (AMC),
cephalexin (CEF), chloramphenicol (CLO), trimethoprim-
sulfamethoxazole (SUT), streptomycin (EST) + gentamicin
(GEN), doxycycline (DOX) + tetracycline (TET), ciproﬂoxacin
(CIP), ceftazidime (CAZ), ceftriaxone (CRO), cefepime (CPM),
cefotaxime (CTX) and aztreonam (ATM) using Clinical Labora-
tory Standards Institute (CLSI) methodologies and interpretive
criteria.9,10
Disk approximation tests using the drugs AMC, CAZ, ATM,
CTX and CPM were performed on all isolates to screen for ESBL
producers as previously described11 and according to CLSI rec-
ommendations (2012 S22). The bacterial strains E. coli ATCC
25922 and Klebsiella pneumoniae 700603 were used as control
strains.
Characterization  and  identiﬁcation  of  beta-lactamase
genes
The presence of the beta-lactamase (bla) genes blaTEM, blaCTX-M
and blaSHV was detected by polymerase chain reactions
(PCR)in third- and fourth-generation cephalosporin- and ATM-
resistant strains classiﬁed as those exceeding the breakpoints
recommended by the CLSI (2012) and those that tested positive
in disk approximation experiments.11 The primers and ampli-
ﬁcation conditions used in PCR assays are listed in Table 1. The
bacterial strains used as positive controls in PCR reactions for
the detection of bla genes were: E. coli H21, E. coli A41 (pre-
viously characterized12), and K. pneumonia (ATCC 700603) for
genes blaTEM, blaCTX-M and blaSHV, respectively. E. coli DH5 was
used as a negative control.
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Table 1 – Primers and ampliﬁcation conditions used in PCR reactions for the detection of ESBL genes and phylogenetic
characterization.
Gene or target region Primers Amplicon size (bp) Annealing temperature (◦C) Reference
blaTEM T1 ATTCTTGAAGACGAAAGGGCCT 1100 55 Wiegand et al.14
T3 TTGGTCTGACAGTTACCAATGC
blaSHV S1 ATGAGTTATATTAGAATGGT  860 58 Fu et al.15
S2 GTTAGCGTTGCCAGTGCTCG
blaCTX CTM-MA CGCTTTGCGATGTGCAG 550 60 Bonnet et al.16
CTX-MB ACCGCGATATCGTTGGT
chu A GACGAACCAACGGTCAGGAT 279
55 Clermont  et al.13
TGCCGCCAGTACCAAAGACA
yja A TGAAGTGTCAGGAGACGCTG 211
ATGGAGAATGCGTTCCTCAAC
tspE4.C2 GAGTAATGTCGGGGCATTCA 
CGCGCCAACAAAGTATTACG
Determination  of  phylogenetic  groups
The E. coli isolates were subjected to phylogenetic classiﬁ-
cation according to the methodology described by Clermont
et al.13 based on standard PCR ampliﬁcation of the genes yjaA,
chuA  and a DNA fragment TspE4.C2. The primers and ampliﬁ-
cation conditions used are shown in Table 1.
PFGE  assays
Paired isolates of E. coli from dogs and owners presenting
similar proﬁles of resistance and ESBL resistance genes were
selected for pulsed ﬁeld gel electrophoresis (PFGE) of XbaI
digested total DNA according to a standardized method-
ology of the Centers for Disease Control and Prevention
(CDC) (http://www.cdc.gov/pulsenet/pathogens/index.html).
The generated PFGE proﬁles of within-household isolates were
compared according criteria proposed by Tenover17: indis-
tinguishable (I) – nodistinct bands; closely related (CR)-2-3
distinct bands; possibly related (PR) – 4–6 distinct bands;
different (D) – more  than seven distinct bands. Restriction frag-
ment proﬁles were also compared by using the Bio Numerics®
software version6.6 (Applied Maths, Austin, TX), using the
Dice similarity index and the UPGMA (Unweighted Pair Group
Method with Arithmetic Mean) clustering method to construct
the dendrograms. E. coli isolates with ≥94% PFGE similarly
were considered to be clonal.5
Statistical  analysis
The prevalence of resistance to antimicrobials, the presence of
ESBL genes and the distribution of phylogenetic groups among
canine, human and control group samples were compared
using the Chi-squared test with p ≤ 0.05 used as the criterion
for statistical signiﬁcance.
Results  and  discussionMultiresistant E. coli strains were selectively isolated from
42 (31.3%) fecal sample pairs from dogs and their owners,
totaling 84 isolates, and from 19 (43.1%) control group sub-
jects. The frequency of multiresistant E. coli obtained from152
fecal samples can reach 89%, according to some studies, with
frequencies that vary according to the selection criteria.18–21
To recover strains that exhibited potential resistance to
multiple antimicrobials, we used cephalothin. Cephalothin
resistance is clinically signiﬁcant because it is frequently
found in situations without strong selectivity (water reser-
voirs and non-hospital locations). Cephalothin resistance
is also associated with other resistance markers, including
markers for chloramphenicol, tetracycline, and trimethoprim-
sulfamethoxazole, which are considered common markers in
our categorization. Gentamicin was also used in our identi-
ﬁcation of multidrug resistance, due to the high correlation
between gentamicin resistance and multiresistance proﬁles
in nosocomial strains.7 Because of this selective isolation
protocol, some samples did not grow in the presence of
the antimicrobials mentioned, and thus we  may have lost
some multiresistant strains sensitive to the drugs used in
the selection. All of the isolates included in our study, how-
ever, were resistant to at least two drug classes, presumably
because they were all subjected to a selective isolation pro-
cedure. When the same resistance proﬁle was observed in
a dog and owner pair, a different method of selection was
used to enhance the detection of lower prevalence clones.
This method, described by Damborg and colleagues,22 entails
selecting colonies that grow in the inhibition zones formed
by the drugs amikacin, gentamicin, ampicillin, ciproﬂoxacin,
cefotaxime, and sulfamethoxazole-trimethoprim on Mac-
Conkey agar, and submitting these for identiﬁcation. This
was  done to enhance the identiﬁcation of multidrug-resistant
strains common to both dogs and owners of subject pairs.
Among the resistant E. coli fecal isolates, 74 patterns
were observed, each with resistance to at least two drug
classes (data not shown). Across all groups, the most fre-
quent resistance patterns were AMP/EST (13.6%) followed by
AMP/EST/SUT (3.9%). There were no signiﬁcant differences
in the resistance frequencies among the tested drugs except
for sulfamethoxazole-trimethoprim for which the human
isolates from owners and control group subjects had statis-
tically higher resistance frequencies than the canine isolates
(p ≤ 0.05). Other studies showed few patterns comparable to
our data.21–23 In a similar study, Skurnik et al.24 compared
fecal E. coli from different animal species and noted that the
resistance prevalence of strains was similar, but dogs showed
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Table 2 – Numbers of resistant E. coli isolates of fecal origin (humans and dogs) for the drugs tested.
Antimicrobials Number of resistant isolates (%)
Dogs
n = 42
Humans (owners)
n = 42
Humans (control)
n  = 19
AMP 36 (85.7) 31 (73.8) 17 (89.4)
AMC 15 (35.7) 10 (23.8) 4 (21.1)
CFE 14 (33.3) 13 (30.9) 8 (42.1)
CAZ 7 (16.6) 3  (7.1) 4  (21.1)
CPM 4 (9.5) 3  (7.1) 3 (15.8)
CTX 8 (19.4) 6 (14.3) 2 (10.5)
CRO 9 (21.4) 6 (14.3) 5 (26.3)
ATM 7 (16.6) 6 (14.3) 5 (26.3)
GEN 13 (30.9) 17 (40.5) 11 (57.8)
EST 28 (66.6) 27 (64.3) 11 (57.8)
CLO 10 (23.8) 14 (33.3) 5 (26.3)
CIP 5 (11.9) 9 (21.4) 2 (10.5)
SUT 13 (30.9) 23 (54.7) 12 (63.2)
TET 21 (50.0) 22 (52.3) 11 (57.8)
DOX 14 (33.3) 11 (26.2) 5 (26.3)
AMP, ampicillin; AMC, amoxicillin + clavulanic acid; CFE, cephalexin; CAZ, ceftazidime; CPM, cefepime; CTX, cefotaxime; CRO, ceftriaxone;
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fATM, aztreonam; GEN, gentamicin; EST, streptomycin; CLO, chloram
tetracycline; DOX, doxycycline.
he highest levels of multiresistant strains like those found in
umans. These data are similar to those obtained in our study.
In our study, the highest frequency of resistance
as recorded for ampicillin, tetracycline, streptomycin,
nd trimethoprim-sulfamethoxazole (Table 2). Resistance
o streptomycin, ampicillin, tetracycline, chloramphenicol
nd trimethoprim-sulfamethoxazole has been observed in
ther studies of dog fecal isolates18–21,23,25 and human fecal
solates.26,27 Aminopenicillins and aminoglycosides appear
ost often among the three classes of drugs with high
requencies of resistance in studies of samples of animal
rigin.6,21,23,28–34 Strains resistant to the carbapenems tested
n this study were not detected.
Importantly, the strains analyzed in this study were
elected using media containing antibiotics, and although
esistance rates may have been higher than reported else-
here, the prevalence data, especially for ampicillin and
treptomycin, were similar to those observed in other studies.
tenske et al.5 also compared the resistance proﬁles of fecal
trains from dogs and their owners, obtaining high frequen-
ies of resistance to cephalothin, ampicillin, and streptomycin
n both groups, a result comparable to our current ﬁndings,
lthough our frequencies were higher and we used cephalexin
ather than cephalothin. Harada et al.35 observed similarities
mong isolates from dogs and humans; however, they showed
igniﬁcant differences between the groups analyzed in terms
f which drugs corresponded to the highest rates of resistance.
Comparisons of strains of clinical origin has also been
 focus of study of the epidemiology of antimicrobial resis-
ance and has shown that the drugs ampicillin, streptomycin
nd sulfamethoxazole-trimethoprim exhibit high frequencies
f resistance in strains of both human origin36–38 and dog
rigin.6,28–33 With regard to isolates from dogs, resistance
o the ﬁrst-generation cephalosporins, including cephalothin
nd cephalexin, was also identiﬁed in the studies cited. Dif-
erences in the proportions of resistance have been notedicol; CIP, ciproﬂoxacin; SUT, sulfamethoxazole + trimethoprim; TET,
in relation to the site of infection, for example, in urinary
infection, pyometra and osteomyelitis, in which different lev-
els of resistance to the same drugs were encountered.18,39–41
Some studies characterizing resistance in strains originat-
ing from human patients have analyzed the prevalence of
resistant infections in samples from hospital patients and
outpatients.42 These studies show many  differences in resis-
tance prevalence, related not only to the origin of the samples
but also to the site of infection, the continent and coun-
try where the study took place as well as the proﬁles of the
patients from which the samples originated. Differences are
also attributed to the repertoire of antibiotics used in the study.
In the current study, 28.5% of the E. coli isolates from
dogs were resistant to at least one antibiotic belonging to
the third- or fourth-generation cephalosporins and were posi-
tive for ESBL by disk-approximation test. This proﬁle occurred
in 16.6% and 36.8% of isolates from dog owners and con-
trol subjects, respectively. These differences, however, were
not signiﬁcant. Resistance to third-and fourth-generation
cephalosporins is suggestive of beta-lactamase production by
the isolates. In our tests, we detected beta-lactam resistance
genes of the blaTEM, blaCTX-M and blaSHV families in isolates of
both human and dog origin (Table 3).
We detected at least one ESBL encoding gene in 26.2% of
the E. coli isolates and all of them were also positive in the
phenotypic tests. However, ﬁve isolates (8H, 9H, 57H, 22F, 38F),
despite presenting phenotypes suggestive of ESBL production,
did not test positive for any of the three bla genes surveyed in
our study. Other ESBL genes may be present in these strains
because the OXA and CMY gene families are also common in
E. coli.43
The blaCTX-M gene was signiﬁcantly more  prevalent in
strains from the control group than in the other two  groups;
furthermore, all ESBL positive isolates in this group were pos-
itive for CTX-M. In dog isolates, the blaTEM gene was present
in 66.7% of the strains that tested positive for ESBL genes, and
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Table 3 – Phylogenetic groups and ESBL genes among fecal E. coli isolates from dogs, their owners, and control human
subjects.
Class Type Number of Isolates (%) Total (%)
Dogs (n = 42) Owners (n = 42) Controls (n = 19)
Phylogenetic group A 21 (50) 24 (57.1) 10 (52.6) 55 (53.4)
B1 09 (21.4) 08 (19.1) 02 (10.5) 19 (18.4)
B2 03 (7.2) 04 (9.5) 00 (0) 07 (6.9)
D 09 (21.4) 06 (14.3) 7 (36.9) 22 (21.3)
ESBL genea blaTEM 3 4 0
blaTEM/blaCTX-M 4 1 3
blaCTX-M 4 2 4
blaTEM/blaCTX-M/blaSHV 1 1 0
Total 12 (28.6) 8 (19.0) 7 (36.8) 27 (26.2)
 testsa All isolates carrying an ESBL gene were also positive in phenotypic
the blaCTX-M gene was detected in 75% of these isolates. Only
8.4% of the dog isolates were positive for the blaSHV gene. In
human strains, the prevalent ESBL gene family was the blaTEM
family. The blaCTX-M gene was present in similar proportions
in strains of human and dog origin from the same household.
The blaSHV gene was detected in 8.4% of the human isolates.
The detection of ESBL genes in isolates of pet dogs was ﬁrst
published in 1988.43 Other studies have also reported the pres-
ence of the bla genes in isolates from dogs, especially isolates
of clinical origin. Different subtypes of the bla gene CTX-
M are often detected in extraintestinal clinical isolates44,45
and in fecal isolates.22,29,46 The blaTEM gene, detected in clin-
ical strains from dogs since 2002,6,28,44,45,47 was also found in
intestinal isolates.19,21,29,46 For the gene blaSHV, data are simi-
lar, with detection in both clinical29,44 and fecal isolates.6,29,48
The prevalence of these genes in dog E. coli strains, however,
is not well established.
The prevalence of ESBL genes in human clinical speci-
mens varies considerably, depending on the origin of the
strains, whether the infection originated in a hospital or in
a community setting, and on the site of infection. Generally,
isolates from infections acquired in hospitals exhibit more
complex proﬁles with broader repertoires of resistance com-
pared to isolates of community-acquired infections. Recent
data indicate a prevalence of ESBL blaCTX-M genes in the
bloodstream49,50 and in other infections in hospital settings.51
Less than a decade ago, TEM and SHV ESBL isolates were
thought to be limited to the hospital environment, and CTX-
MESBL isolates were detected in urinary tract infections in
community settings.52 Currently, the most prevalent ESBL
gene identiﬁed in isolates across many  countries is the CTX-
M gene, particularly the CTX-M-15 gene, which is associated
with IncF variant plasmids.53 The epidemiological proﬁle of
highly mutable enterobacteria can be considered an addi-
tional factor in this variability, which greatly inﬂuenced the
spread of plasmids and other transposable elements act-
ing as mobile carriers of multiple resistance genes against
drugs, including aminoglycosides, chloramphenicol, tetracy-
cline, and trimethoprim-sulfamethoxazole.54In our study, the distribution of phylogenetic groups in the
host species examined was similar in all groups, with the phy-
logenetic group A being the most prevalent (Table 3), occurring.
in 50% of the canine strains, 57.2% of the human strains and
52.6% of the control group. For fecal strains, this ﬁnding is
consistent with literature that describes the majority of iso-
lates from commensal strains, regardless of their repertoire of
resistance, belonging to groups A or B1.55
The distribution of phylogroups among dog isolates, how-
ever, has been shown to differ in terms of prevalence
in extraintestinal, commensal and clinical samples. In the
case of extraintestinal isolates, where the predominant phy-
logroups were expected to be groups B2 and D, Gibson et al.32
found no isolates belonging to group B2, whereas Maynard
et al.6 reported a 63% frequency of the B2 phylogroup in
extraintestinal samples. Moreover, commensal strains from
animals in general predominantly included the groups A and
B1. Fecal strains from dogs in a study by Harada et al.35 showed
a high prevalence of group B2. Davis et al.25 also observed
a predominance of B2 (and D) in their isolates from differ-
ent anatomical regions of healthy dogs, including the rectal
area.
Studies comparing human and canine isolates in terms
of antimicrobial resistance proﬁles used samples of clinical
origin, which had a higher prevalence of groups B2 and D,
as expected. However, Harada et al.35 analyzed fecal sam-
ples from dogs and their owners without using antimicrobial
agents for selective isolation, and they observed a higher
prevalence of group B2, whereas Damborg et al.22 reported
that in their experiments, human fecal isolates more  often
belonged to group A and the dog isolates to group B1. A study
by Clermont et al.4 showed that extraintestinal infection is
mostly caused by E. coli strains of group B2. An assessment
of extraintestinal clinical isolates from dogs revealed that the
two  main groups of E. coli resistant to ﬂuoroquinolones are A
and D.56 Data reported in a study by Skurnik et al.,57 however,
suggested that clinical isolates from group B2 are less resistant
to antimicrobials than non-B2 isolates.
In our tests, 12 ESBL isolates belonged to group A and 10
to group D, and no ESBL isolates carrying the genes blaTEM,
blaSHV and blaCTX-M were included in group B2. Our data sug-
gest that resistant commensal E. coli strains do not necessarily
belong to the phylogroups expected from resistant pathogenic
strains. The explanation for this observation requires further
investigation.
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Table 4 – Resistance, ESBL genes and genetic relatedness of pairs of E. coli isolates of fecal origin (dogs and humans
within a household) with similar proﬁles.
Isolatea Host species Resistance phenotypeb ESBL genes Phylogroup PFGEc
blaTEM blaCTX-M blaSHV
15F Dog AMP AMC CFE CAZ CTX ATM − + − D −
15H Human AMP AMC CFE CTX CRO −  + − A −
23F Dog AMP EST CLO SUT TET −  − − D I
23H Human AMP EST CLO SUT TET − − − A I
27F Dog AMP CFE EST − − − B1 D
27H Human AMP CFE EST − − − A D
48F Dog AMP CFE CAZ CTX CRO GEN EST CLO SUT + + − A I
48H Human AMP CFE CTX CRO GEN EST CLO SUT TET + + − B1 I
49F Dog AMP AMC CFE CPM CTX CRO GEN EST
CLO CIP SUT TET
−  + − B1 D
49H Human AMP CFE CPM CTX CRO GEN EST CLO SUT
TET
+ − − B1 D
59F Dog AMP EST − − − B1 D
59H Human AMP EST − − − B1 D
61F Dog AMP AMC EST CLO SUT TET DOX − − − B2 I
61H Human AMP AMC EST CLO SUT TET DOX − − − B2 I
58F Dog AMP AMC EST CLO + − − B1 −
58H Human AMP EST CLO − − − B1 −
92F Dog AMP CAZ ATM GEN EST CIP SUT TET DOX + + + B1 I
92H Human AMP ATM GEN EST CIP SUT TET DOX + − + B1 I
a The letter F designates canine fecal isolates; H, human fecal isolates (dog owners).
b AMP, ampicilin; AMC, amoxicillin + clavulanic acid; CFE, cephalexin; CAZ, ceftazidime; CPM, cefepime; CTX, cefotaxime; CRO, ceftriaxone;
ATM, aztreonam; GEN, gentamicin; EST, streptomycin; CLO, chloramphenicol; CIP, ciproﬂoxacin; SUT, sulfametoxazol + trimethoprim; TET,
tetracycline; DOX, doxycycline.
c Tenover criteria applied for each isolate pair from the same household: I, indistinguishable; D, different; − not possible to compare due the
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mDNA degradation of one isolate during the PFGE restriction.
The presence of ESBL genes was similar in E. coli isolates
rom dogs and from their owners, especially in some human
nd dog isolates from the same household. Thus, 18 E. coli
solates comprising nine isolate pairs from dogs and owners
hat presented similar antimicrobial resistance, ESBL genes
nd phylogenetic group proﬁles were selected for PFGE assays
Table 4). By applying the Tenover criteria to each isolate pair
rom the same household, we  detected four isolate pairs with
dentical patterns. The dendrogram constructed with the PFGE
roﬁles of these isolates reinforces the relatedness between
ig. 1 – Dendrogram showing genomic PFGE ﬁngerprint patterns
imilar resistance proﬁles. The dendrogram was constructed usi
ethods. The degree of similarity (%) is shown on the scale bar.these four strain pairs, and it shows a strong similarity to an
isolate pair with another dog isolate (Fig. 1).
Some strains recovered from dogs and owners showed
phenotypic and genotypic similarities suggesting a clonal rela-
tionship. Indeed, we demonstrated in this study the sharing
of multiresistant E. coli strains in 9.5% (4/42) of the pairs of
isolates from the dogs and their owners that we studied.
In comparisons between E. coli isolates of human and dog
origin, many  similarities have been identiﬁed in the vari-
ous traits studied, especially with regard to the repertoire of
 of fecal E. coli isolates from dogs (F) and owners (H) with
ng the Dice similarity coefﬁcient and UPGMA clustering
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virulence of the strains.5,6,35,58,59 It has been suggested that
the host speciﬁcity of E. coli strains is determined by spe-
ciﬁc adhesions.4 Studies have shown a similar occurrence of
virulence factors associated with extraintestinal pathogenic
E. coli in strains isolated from dogs and humans.6,58,60 Some
studies suggest that uropathogenic E. coli strains are shared
between dogs and humans,58 whereas others show a signif-
icant diversity in the virulence repertoires of strains isolated
from distinct species or even within the same species.6,35
Regarding the genetics of resistance, the data are some-
what heterogeneous and differ depending on the population
and the geographic region of origin as well as on whether the
strains are commensal or pathogenic.5,35,48 Despite the fact
that a positive correlation between the presence of plasmids
and integrons with a multiresistant phenotype is described in
several studies,24,61 additional factors that shape the genetic
structure of these strains are important.55,62 Comparisons of
resistance proﬁles are not always performed on strains from
cohabiting individuals, and samples are therefore not always
epidemiologically related. The characterization, therefore, of
related human and canine isolates, as well as the possibility
of sharing multiresistant strains between humans and dogs,
requires further study in Brazil.
Conclusion
We  detected the simultaneous presence of multidrug-
resistant E. coli in dogs and their owners, albeit with different
phenotypic proﬁles of antibiotic resistance, especially for
ESBLs. Furthermore, some strains from dogs and humans of
the same household had similar resistance patterns, ESBL
genes, identical phylogenetic groups and identical or closely
related PFGE proﬁles. These data demonstrate high degrees
of homology and therefore the possibility that resistant E. coli
clones are circulating between individuals and animals in the
same environment. Indeed some strains showed clonal rela-
tionships indicating within-household sharing.
In addition, our data suggest that the prevalence of
antimicrobial-resistant commensal E. coli is very similar in
dogs and humans and that there is no difference among the
resistant E. coli isolated from dog-owners and humans without
pet dogs.
This area needs more  accurate investigations and many
uncertainties remain regarding how resistance arises and
spreads in the environment and among cohabiting humans
and domestic animals.
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